India scraps local trials for Covid vaccines to fast-track imports
3 years, 6 months ago

India scraps local trials for Covid vaccines to fast-track imports

Hindustan Times  

The Centre on Thursday scrapped local trials for "well-established" foreign coronavirus disease vaccines to fast-track imports, news agency Reuters reported. Last month, India pledged to fast-track approvals for foreign vaccines but its insistence on local trials was a key reason for stalled discussions with Pfizer. This was earlier announced by Niti Aayog member Dr VK Paul in a statement, which said that the vaccine approved by the US Food and Drug Administration, European Medicines Agency and other reputed bodies, will not be required to undergo prior bridging trial and trials for “well-established” vaccines have been waived altogether. India started its nationwide vaccination programme on January 16 this year after the country's drugs regulator DCGI approved two vaccines - AstraZeneca's Covishield and Covaxin made by local firm Bharat Biotech.

India Vaccines Covid Vaccine Local Trials  trials  india  discussions  dr  covid  fasttrack  wellestablished  vaccination  scraps  vaccine  paul  vaccines  local  imports  centre

History of this topic

India to undertake mega study of covid-19 samples to help prepare for future pandemics
1 month, 2 weeks ago

India to undertake mega study of covid-19 samples to help prepare for future pandemics

Live Mint  

New Delhi: The Department of Biotechnology plans to undertake a study of thousands of samples and clinical material collected during covid-19 to help Indian scientists understand the susceptibility of individuals and changes in metabolic activity that will be useful in fighting future pandemics. The department will give the Indian SARS-CoV-2 Genomics Consortium, a consortium of 54 laboratories, the mandate to …

Health Talk | Why India waiving off local clinical trials for globally approved new drugs is good news
4 months, 1 week ago

Health Talk | Why India waiving off local clinical trials for globally approved new drugs is good news

Hindustan Times  

On August 7, India’s drugs regulatory agency, Central Drugs Standard Control Organisation, issued an order that allowed waiving off local clinical trials for approval of certain categories of new and novel drugs in the Indian market that have already been approved for use globally by regulators of countries that follow strict quality control. Local clinical trials or bridging studies as …

Govt Waives Clinical Trials for Several Drugs Approved in Major Western Markets
4 months, 2 weeks ago

Govt Waives Clinical Trials for Several Drugs Approved in Major Western Markets

News 18  

The central government has decided to waive the requirement for clinical trials in India if the drugs are approved in the United States, United Kingdom, Japan, Australia, Canada, and European Union. According to the order issued by the drug regulatory agency of India, CDSCO, on Wednesday, the central government has permitted the waiver of “local clinical trials” for approval of …

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 1 month ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

Is India ready for Controlled Human Infection Studies? | In Focus podcast
1 year, 3 months ago

Is India ready for Controlled Human Infection Studies? | In Focus podcast

The Hindu  

How do we understand how an infection affects the human body? One way scientists do this is through Controlled Human Infection Studies or CHIS, also known as human challenge studies. India has so far stayed away from such studies, because of the many ethical issues involved: the deliberate harm caused and the potential risk of exploitation since volunteers are paid …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 6 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 6 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

Explained | What are the problems with India’s clinical trials registry?
1 year, 8 months ago

Explained | What are the problems with India’s clinical trials registry?

The Hindu  

The speedy approval of Covid-19 vaccines during the SARS-CoV-2 pandemic spotlighted the importance of clinical trials. Hosted with the Indian Council of Medical Research’s National Institute of Medical Statistics, the CTRI is a free, online public-record system to register clinical trials being conducted in India. The CTRI is one of 17 public trial registries under the International Clinical Trials Registry …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

Bihar will buy Covid vaccines in absence of supply from Centre: CM Nitish
1 year, 8 months ago

Bihar will buy Covid vaccines in absence of supply from Centre: CM Nitish

Hindustan Times  

PATNA: Chief minister Nitish Kumar said the state government would buy vaccines against coronavirus on its own to continue inoculating its people as Centre is not providing them to the state, as per a communique from the chief minister’s office on Monday. The communique, however, was silent on the state’s unmet demand for Covid-19 vaccines, how it would buy them …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 9 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

History TV18's 'The Vial': India's COVID vaccine journey; a true success story
1 year, 9 months ago

History TV18's 'The Vial': India's COVID vaccine journey; a true success story

Firstpost  

When COVID broke out the medical community had no idea how to deal with it. ‘The Vial’ also chronicles the development of the Covishield vaccine — From isolation of the strain at Pune’s National Institute of Virology to manufacturing billions of vials of two of the world’s most effective vaccine candidates in record time to cater to the country’s massive …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 9 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it
1 year, 11 months ago

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it

News 18  

Pfizer CEO Albert Bourla being quizzed at Davos by journalists about the company’s Covid-19 vaccine has triggered the BJP to take on top Congress and AAP leaders for earlier pushing for the Pfizer shot to be brought to India. But facts show that not only was the vaccine offered by Pfizer and Moderna exorbitantly priced at over $20 for each …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News  

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

Airports to randomly test 2%international flyers for Covid-19
2 years ago

Airports to randomly test 2%international flyers for Covid-19

Hindustan Times  

India has begun randomly testing 2% of international travellers coming to the country for Covid-19 and could consider making it mandatory for all if required, Union health minister Mansukh Mandaviya told Parliament on Thursday, as several countries, particularly China, reported a spike in cases. Later on Thursday, officials disclosed a letter sent by Union health secretary Rajesh Bhushan to civil …

A PLI-type scheme for 'atmanirbhar' vaccine industry
2 years ago

A PLI-type scheme for 'atmanirbhar' vaccine industry

Live Mint  

The government will likely unveil a ₹2,500 crore financial assistance programme to boost domestic production of vaccine raw materials to enhance self-reliance amid a resurgence of covid cases worldwide, two officials familiar with the development said. Cement investors see Q3 with mixed feelings While India is a global leader in vaccine production, it imports key raw materials needed for manufacturing. …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

Health Ministry asks States to hike genome sequencing for the SARS-CoV-2 coronavirus
2 years ago

Health Ministry asks States to hike genome sequencing for the SARS-CoV-2 coronavirus

The Hindu  

With a spurt in coronavirus cases reported in China, the United States and South Korea, India’s Health Ministry has asked States to bolster genome sequencing of coronavirus samples. “In view of the spurt in positive cases, it is essential to gear up the whole-genome sequencing of positive case samples to track variants through Indian Sars Cov2 Genomics Consortium network. India …

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast
2 years ago

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast

The Hindu  

Last month, the Central government, in an affidavit to the Supreme Court, said that it cannot be held liable to pay compensation for deaths caused by adverse reactions to the COVID-19 vaccine. The affidavit was filed in a case in response to a petition filed by the parents of two young women, who allegedly died due to adverse reactions following …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Explained | Can vaccine distribution be made fairer?
2 years, 1 month ago

Explained | Can vaccine distribution be made fairer?

The Hindu  

The story so far: The Global Dashboard for Vaccine Equity, a joint effort by the United Nations Development Programme, the World Health Organization and the University of Oxford with cooperation across the UN system, has put out recent data that justifies the vexatious core of the vaccine distribution programme: Only one in four people has been vaccinated with at least …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k
2 years, 3 months ago

Covid-19: India logs nearly 5,000 new infections, active cases drop below 45k

Live Mint  

India has witnessed a marginal decline in daily Covid-19 cases on Saturday with country recording 4,912 new infections in the past 24 hours, according to an update given by the Ministry of Health and Family Welfare. The country conducted 3,03,888 Covid tests in the last 24 hours, with the total number of tests conducted so far at 89.33 crore. The …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

Monkeypox vaccines: India puts emergency buying on hold for now - here’s why
2 years, 3 months ago

Monkeypox vaccines: India puts emergency buying on hold for now - here’s why

Live Mint  

According to those with knowledge of the situation, India has chosen to delay purchasing the monkeypox vaccine on an emergency basis for the time being because the number of cases reported across the nation has not increased. Serum Institute of India, one of the first organisations to express interest in bringing the monkeypox vaccine into India, put its proposal on …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 4 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

How India Pursued Covid-19 Vaccine Diplomacy Amid Vaccine Nationalism By Rich Nations
2 years, 4 months ago

How India Pursued Covid-19 Vaccine Diplomacy Amid Vaccine Nationalism By Rich Nations

ABP News  

The last 30 months have seen the world getting ravaged by Covid-19. When rich nations of the Global North were stockpiling and hoarding Covid-19 vaccines, many times more than their population, India not only spearheaded one of the largest vaccine drives within the country but also shared the vaccine doses with low- and middle-income countries worldwide. India supplied 23.9 crore …

Why India Is Becoming One Of The Most Preferred Destination For Clinical Drug Trials
2 years, 4 months ago

Why India Is Becoming One Of The Most Preferred Destination For Clinical Drug Trials

ABP News  

At a time when several infectious diseases are emerging and different variants of coronavirus are popping up across the globe, high quality clinical trials have become critical for pharma companies to ensure the efficacy and safety of a drug before it is rolled out for the public. The Covid-19 pandemic has re-emphasised the importance of high quality drug trials and …

COVID-19, arguably, has become endemic in India
2 years, 4 months ago

COVID-19, arguably, has become endemic in India

The Hindu  

The infectious disease ‘outbreaks’ or ‘epidemics’ or ‘pandemics’ share a fate — there is a day when the majority of them run their course and fade away. Much opinion After the third wave in January 2022, India saw the lowest number of daily new COVID-19 cases in March and April this year. In fact, in the last two months every …

India reports 45 covid deaths, over 21,000 fresh cases in a day
2 years, 5 months ago

India reports 45 covid deaths, over 21,000 fresh cases in a day

Live Mint  

New Delhi: India reported 45 covid-19 deaths and 21,566 new cases in the last 24 hours, the union health ministry data stated on Thursday. The central government reviewed covid-19 situation in 115 districts of nine states showing an upsurge in cases and positivity rate, and flagged concerns regarding low levels of testing and vaccination. States were directed to report and …

Centre reviews Covid situation in states witnessing surge in cases, flags low level of testing
2 years, 5 months ago

Centre reviews Covid situation in states witnessing surge in cases, flags low level of testing

India TV News  

Highlights Several states are witnessing surge in Covid cases The Centre has advised states to boost vaccination The govt has also flagged drop in Covid testing Covid News: The Centre is reviewing COVID-19 situation in 115 districts across 9 states that are showing an upsurge in Covid cases and positivity. rime Minister Narendra Modi on Wednesday said India's vaccination drive …

Two billion Covid vaccine doses given in India, government says
2 years, 5 months ago

Two billion Covid vaccine doses given in India, government says

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy India’s health ministry on Sunday …

DC Edit | A good move, as Covid cases up
2 years, 5 months ago

DC Edit | A good move, as Covid cases up

Deccan Chronicle  

The decision of the Union government to push the vaccination programme further against Covid-19 by making the precaution dose free for those who are aged above 18 years has come not one day sooner. That only one per cent of the eligible population aged between 18 and 59 has got the precaution dose calls on the government to redouble its …

Free Covid booster doses will create healthier country: PM Modi
2 years, 5 months ago

Free Covid booster doses will create healthier country: PM Modi

India Today  

Prime Minister Narendra Modi on Wednesday said the government's decision to administer free precautionary doses of Covid-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country. As part of 'Azadi Ka Amrit Mahotsav' celebrations, free precautionary doses of Covid-19 vaccines will be administered to all citizens above the age of 18 at …

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence
2 years, 5 months ago

UK-India Relationship Has Emerged Stronger Than Ever After the Covid Turbulence

News 18  

With the UK-India week on the cusp, it becomes pertinent to discuss how the United Kingdom and India have weathered rough storms during the pandemic years to come out closer than ever. It is this three-way partnership that has now been at the helm of having already delivered over 2 billion affordable, effective vaccines which have now been administered to …

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study
2 years, 6 months ago

Over 42 lakh deaths in India prevented by COVID-19 vaccines in 2021: Lancet study

The Hindu  

COVID-19 vaccines prevented over 42 lakh potential deaths in India in 2021, said a study published in The Lancet Infectious Diseases journal, which based its findings on estimates of "excess" mortalities in the country during the pandemic. In the first year of the vaccination programme, 19.8 million out of a potential 31.4 million COVID-19 deaths were prevented worldwide, according to …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora
2 years, 6 months ago

Modi@8: India’s Covid Vax Drive is a Myth Breaker in Public Health Space, Writes NTAGI Head NK Arora

News 18  

Not so long back, a reputed international media-house had predicted gloomily that it could take over a decade for India to vaccinate its 1.4 billion population against Covid-19. The resounding success of this drive, which has been a proactive, pre-emptive, and graded response in the management of Covid-19 has been a myth-breaker on several fronts in the public health space …

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing
2 years, 7 months ago

World Economic Forum | India right example for ensuring vaccine equity, stepping up manufacturing

The Hindu  

Hailing India for ramping up its COVID-19 vaccine manufacturing at the right time and for ensuring supplies to the rest of the world, leaders at the World Economic Forum on Monday said everyone else needs to follow the Indian model to ensure vaccine equity and wider inoculation. Bucher said India has been a good example and the same needs to …

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs
2 years, 7 months ago

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs

The Hindu  

As India nears the 200-crore COVID-19 vaccination mark, Serum Institute of India’s Covishield accounts for 80 per cent of the jabs, while Bharat Biotech’s Covaxin accounts for 16.75 per cent jabs. As of date, India has granted emergency usage authorisation to nine COVID-19 vaccine candidates in total – Covishield, Covaxin, Covovax, Corbevax, Zydus Cadila’s ZyCoV-D, Moderna’s Spikevax, Sputnik-V, Sputnik Light, …

India to Participate in Global Trials to Assess Safety of Covishield among Cancer, HIV, Transplant Patients
2 years, 7 months ago

India to Participate in Global Trials to Assess Safety of Covishield among Cancer, HIV, Transplant Patients

News 18  

India will soon kick-start trials to assess the safety and immunity of AstraZeneca’s Covid-19 vaccine, dubbed Covishield in India, among unvaccinated immunocompromised adults, News18.com has learnt. According to the study planned on the global scale, previously unvaccinated immunocompromised adults will be enrolled in five disease cohorts — solid organ transplant, hematopoietic stem cell transplant, solid organ cancer patients receiving cytotoxic …

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

Indian Covid vaccines better than Pfizer, Moderna, says Adar Poonawalla

India Today  

Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that Covid-19 vaccines that are made in India, have provided more protection against coronavirus infection than vaccines like Pfizer and Moderna. Speaking to news agency ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and …

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla
2 years, 8 months ago

COVID-19: Indian vaccines better than Pfizer, Moderna, says Adar Poonawalla

Firstpost  

The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla New Delhi: Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that “Made in India” COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. “The …

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO
2 years, 8 months ago

SII has stockpile of 200 mn doses; India better prepared to fight Covid: CEO

Hindustan Times  

Chief executive officer of Serum Institute of India Adar Poonawalla on Tuesday said the company has a stockpile of 200 million doses of Covishield, while it has already exported 40 million doses of Covovax to European countries and Australia. Serum Institute of India CEO Adar Poonawalla speaks at the 'AIMA Leadership Conclave' in New Delhi on Tuesday, "We have a …

Weighing the choices: on precautionary vaccine doses
2 years, 8 months ago

Weighing the choices: on precautionary vaccine doses

The Hindu  

As India sees a steady slump in its daily coronavirus count, the Centre has announced opening up the third, or ‘precautionary doses’, to everyone over 18 years. A major aspect of vaccines is the risk of adverse events following vaccination, and previous experience has suggested that certain vaccines may induce a higher risk of blood clots in younger populations. With …

Discover Related